Cargando…

Anti-Atherosclerosis Effect of Angong Niuhuang Pill via Regulating Th17/Treg Immune Balance and Inhibiting Chronic Inflammatory on ApoE(-/-) Mice Model of Early and Mid-Term Atherosclerosis

Angong Niuhuang Pill (ANP) is a well-known patented Chinese medicine which is used for hundreds of years for treating the central nervous system diseases. Atherosclerosis is a poly-aetiological chronic inflammatory vascular disease. Preventing inflammation is fundamental for treating atherosclerosis...

Descripción completa

Detalles Bibliográficos
Autores principales: Fan, Qinghong, Liu, Yujuan, Rao, Jiaoyu, Zhang, Zhe, Xiao, Wei, Zhu, Tao, Chai, Xiaomeng, Ye, Kaihe, Ning, Na, Yin, Zhen, Chai, Yushuang, Xu, Yimin, Lan, Ruirui, Verkhratsky, A, Nie, Hong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7005527/
https://www.ncbi.nlm.nih.gov/pubmed/32082145
http://dx.doi.org/10.3389/fphar.2019.01584
_version_ 1783494954261151744
author Fan, Qinghong
Liu, Yujuan
Rao, Jiaoyu
Zhang, Zhe
Xiao, Wei
Zhu, Tao
Chai, Xiaomeng
Ye, Kaihe
Ning, Na
Yin, Zhen
Chai, Yushuang
Xu, Yimin
Lan, Ruirui
Verkhratsky, A
Nie, Hong
author_facet Fan, Qinghong
Liu, Yujuan
Rao, Jiaoyu
Zhang, Zhe
Xiao, Wei
Zhu, Tao
Chai, Xiaomeng
Ye, Kaihe
Ning, Na
Yin, Zhen
Chai, Yushuang
Xu, Yimin
Lan, Ruirui
Verkhratsky, A
Nie, Hong
author_sort Fan, Qinghong
collection PubMed
description Angong Niuhuang Pill (ANP) is a well-known patented Chinese medicine which is used for hundreds of years for treating the central nervous system diseases. Atherosclerosis is a poly-aetiological chronic inflammatory vascular disease. Preventing inflammation is fundamental for treating atherosclerosis in early stages. In this study, we investigated the protective effects and possible mechanisms of ANP action on a high-fat diet induced early and mid-term atherosclerosis ApoE(-/-) mice. The effects of ANP were compared with accepted drug simvastatin. Twelve male C57BL/6J mice were used as the control group, and 60 male ApoE(-/-) mice were randomly divided into five groups: Model group, Simvastatin group, Low-, Medium-, and High-dose ANP group these groups received, respectively, saline, simvastatin (3.0mg/kg), low-dose ANP (0.25 g/kg), medium-dose ANP (0.50 g/kg), and high-dose ANP (1.0 g/kg), once every other day for 10 weeks. After administration, serum biochemical indices were detected by the automatic biochemical analyzer, the concentrations of IL-6 and IL-10 in the serum were assayed by ELISA, expression levels of IL-1β, TNF-α, MMP-2, MMP-9, CCL2, and its receptor CCR2 in the full-length aorta, and expression levels of transcription factors Foxp3, RORγt in the spleen were assayed via western blotting and RT-qPCR. Flow cytometry was used to analyze Th17 cells and Treg cells. Pathological and histological analysis was completed on aortic root. ANP decreased LDL/HDL ratio, concentrations of IL-6 while increased IL-10 in serum. Moreover, ANP down-regulated the expression levels of IL-1β, TNF-α, MMP-2, MMP-9, CCL2, and CCR2 receptor in the full-length aorta. In addition, ANP decreased Th17 cells and expression levels of transcription factor RORγt, increased Treg cells and expression levels of transcription factor Foxp3. ANP decreased content of collagen fibers and infiltration of inflammatory cells in the aortic root. In conclusion, we demonstrated that ANP has anti-atherosclerosis effects on a high-fat diet induced ApoE(-/-) mice early and mid-term AS model via regulating Th17/Treg balance, inhibiting chronic inflammation, reducing plaque collagen fibers, and reducing inflammatory cells infiltration, to exert its multi-channel multi-target anti-early and mid-term AS effects.
format Online
Article
Text
id pubmed-7005527
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-70055272020-02-20 Anti-Atherosclerosis Effect of Angong Niuhuang Pill via Regulating Th17/Treg Immune Balance and Inhibiting Chronic Inflammatory on ApoE(-/-) Mice Model of Early and Mid-Term Atherosclerosis Fan, Qinghong Liu, Yujuan Rao, Jiaoyu Zhang, Zhe Xiao, Wei Zhu, Tao Chai, Xiaomeng Ye, Kaihe Ning, Na Yin, Zhen Chai, Yushuang Xu, Yimin Lan, Ruirui Verkhratsky, A Nie, Hong Front Pharmacol Pharmacology Angong Niuhuang Pill (ANP) is a well-known patented Chinese medicine which is used for hundreds of years for treating the central nervous system diseases. Atherosclerosis is a poly-aetiological chronic inflammatory vascular disease. Preventing inflammation is fundamental for treating atherosclerosis in early stages. In this study, we investigated the protective effects and possible mechanisms of ANP action on a high-fat diet induced early and mid-term atherosclerosis ApoE(-/-) mice. The effects of ANP were compared with accepted drug simvastatin. Twelve male C57BL/6J mice were used as the control group, and 60 male ApoE(-/-) mice were randomly divided into five groups: Model group, Simvastatin group, Low-, Medium-, and High-dose ANP group these groups received, respectively, saline, simvastatin (3.0mg/kg), low-dose ANP (0.25 g/kg), medium-dose ANP (0.50 g/kg), and high-dose ANP (1.0 g/kg), once every other day for 10 weeks. After administration, serum biochemical indices were detected by the automatic biochemical analyzer, the concentrations of IL-6 and IL-10 in the serum were assayed by ELISA, expression levels of IL-1β, TNF-α, MMP-2, MMP-9, CCL2, and its receptor CCR2 in the full-length aorta, and expression levels of transcription factors Foxp3, RORγt in the spleen were assayed via western blotting and RT-qPCR. Flow cytometry was used to analyze Th17 cells and Treg cells. Pathological and histological analysis was completed on aortic root. ANP decreased LDL/HDL ratio, concentrations of IL-6 while increased IL-10 in serum. Moreover, ANP down-regulated the expression levels of IL-1β, TNF-α, MMP-2, MMP-9, CCL2, and CCR2 receptor in the full-length aorta. In addition, ANP decreased Th17 cells and expression levels of transcription factor RORγt, increased Treg cells and expression levels of transcription factor Foxp3. ANP decreased content of collagen fibers and infiltration of inflammatory cells in the aortic root. In conclusion, we demonstrated that ANP has anti-atherosclerosis effects on a high-fat diet induced ApoE(-/-) mice early and mid-term AS model via regulating Th17/Treg balance, inhibiting chronic inflammation, reducing plaque collagen fibers, and reducing inflammatory cells infiltration, to exert its multi-channel multi-target anti-early and mid-term AS effects. Frontiers Media S.A. 2020-01-31 /pmc/articles/PMC7005527/ /pubmed/32082145 http://dx.doi.org/10.3389/fphar.2019.01584 Text en Copyright © 2020 Fan, Liu, Rao, Zhang, Xiao, Zhu, Chai, Ye, Ning, Yin, Chai, Xu, Lan, Verkhratsky and Nie http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Fan, Qinghong
Liu, Yujuan
Rao, Jiaoyu
Zhang, Zhe
Xiao, Wei
Zhu, Tao
Chai, Xiaomeng
Ye, Kaihe
Ning, Na
Yin, Zhen
Chai, Yushuang
Xu, Yimin
Lan, Ruirui
Verkhratsky, A
Nie, Hong
Anti-Atherosclerosis Effect of Angong Niuhuang Pill via Regulating Th17/Treg Immune Balance and Inhibiting Chronic Inflammatory on ApoE(-/-) Mice Model of Early and Mid-Term Atherosclerosis
title Anti-Atherosclerosis Effect of Angong Niuhuang Pill via Regulating Th17/Treg Immune Balance and Inhibiting Chronic Inflammatory on ApoE(-/-) Mice Model of Early and Mid-Term Atherosclerosis
title_full Anti-Atherosclerosis Effect of Angong Niuhuang Pill via Regulating Th17/Treg Immune Balance and Inhibiting Chronic Inflammatory on ApoE(-/-) Mice Model of Early and Mid-Term Atherosclerosis
title_fullStr Anti-Atherosclerosis Effect of Angong Niuhuang Pill via Regulating Th17/Treg Immune Balance and Inhibiting Chronic Inflammatory on ApoE(-/-) Mice Model of Early and Mid-Term Atherosclerosis
title_full_unstemmed Anti-Atherosclerosis Effect of Angong Niuhuang Pill via Regulating Th17/Treg Immune Balance and Inhibiting Chronic Inflammatory on ApoE(-/-) Mice Model of Early and Mid-Term Atherosclerosis
title_short Anti-Atherosclerosis Effect of Angong Niuhuang Pill via Regulating Th17/Treg Immune Balance and Inhibiting Chronic Inflammatory on ApoE(-/-) Mice Model of Early and Mid-Term Atherosclerosis
title_sort anti-atherosclerosis effect of angong niuhuang pill via regulating th17/treg immune balance and inhibiting chronic inflammatory on apoe(-/-) mice model of early and mid-term atherosclerosis
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7005527/
https://www.ncbi.nlm.nih.gov/pubmed/32082145
http://dx.doi.org/10.3389/fphar.2019.01584
work_keys_str_mv AT fanqinghong antiatherosclerosiseffectofangongniuhuangpillviaregulatingth17tregimmunebalanceandinhibitingchronicinflammatoryonapoemicemodelofearlyandmidtermatherosclerosis
AT liuyujuan antiatherosclerosiseffectofangongniuhuangpillviaregulatingth17tregimmunebalanceandinhibitingchronicinflammatoryonapoemicemodelofearlyandmidtermatherosclerosis
AT raojiaoyu antiatherosclerosiseffectofangongniuhuangpillviaregulatingth17tregimmunebalanceandinhibitingchronicinflammatoryonapoemicemodelofearlyandmidtermatherosclerosis
AT zhangzhe antiatherosclerosiseffectofangongniuhuangpillviaregulatingth17tregimmunebalanceandinhibitingchronicinflammatoryonapoemicemodelofearlyandmidtermatherosclerosis
AT xiaowei antiatherosclerosiseffectofangongniuhuangpillviaregulatingth17tregimmunebalanceandinhibitingchronicinflammatoryonapoemicemodelofearlyandmidtermatherosclerosis
AT zhutao antiatherosclerosiseffectofangongniuhuangpillviaregulatingth17tregimmunebalanceandinhibitingchronicinflammatoryonapoemicemodelofearlyandmidtermatherosclerosis
AT chaixiaomeng antiatherosclerosiseffectofangongniuhuangpillviaregulatingth17tregimmunebalanceandinhibitingchronicinflammatoryonapoemicemodelofearlyandmidtermatherosclerosis
AT yekaihe antiatherosclerosiseffectofangongniuhuangpillviaregulatingth17tregimmunebalanceandinhibitingchronicinflammatoryonapoemicemodelofearlyandmidtermatherosclerosis
AT ningna antiatherosclerosiseffectofangongniuhuangpillviaregulatingth17tregimmunebalanceandinhibitingchronicinflammatoryonapoemicemodelofearlyandmidtermatherosclerosis
AT yinzhen antiatherosclerosiseffectofangongniuhuangpillviaregulatingth17tregimmunebalanceandinhibitingchronicinflammatoryonapoemicemodelofearlyandmidtermatherosclerosis
AT chaiyushuang antiatherosclerosiseffectofangongniuhuangpillviaregulatingth17tregimmunebalanceandinhibitingchronicinflammatoryonapoemicemodelofearlyandmidtermatherosclerosis
AT xuyimin antiatherosclerosiseffectofangongniuhuangpillviaregulatingth17tregimmunebalanceandinhibitingchronicinflammatoryonapoemicemodelofearlyandmidtermatherosclerosis
AT lanruirui antiatherosclerosiseffectofangongniuhuangpillviaregulatingth17tregimmunebalanceandinhibitingchronicinflammatoryonapoemicemodelofearlyandmidtermatherosclerosis
AT verkhratskya antiatherosclerosiseffectofangongniuhuangpillviaregulatingth17tregimmunebalanceandinhibitingchronicinflammatoryonapoemicemodelofearlyandmidtermatherosclerosis
AT niehong antiatherosclerosiseffectofangongniuhuangpillviaregulatingth17tregimmunebalanceandinhibitingchronicinflammatoryonapoemicemodelofearlyandmidtermatherosclerosis